Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia (Q45168867)
Jump to navigation
Jump to search
scientific article published on 30 November 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia |
scientific article published on 30 November 2004 |
Statements
1 reference
Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia (English)
1 reference
Hagop Kantarjian
1 reference
Srdan Verstovsek
1 reference
Susan O'Brien
1 reference
Alfonso Quintas-Cardama
1 reference
Mary Beth Rios
1 reference
Guillermo Garcia-Manero
1 reference
Jorge Cortes
1 reference
Armand Glassman
1 reference
Kimberly Hayes
1 reference
Moshe Talpaz
1 reference
B Nebiyou Bekele
1 reference
Xian Zhou
1 reference
30 November 2004
1 reference
Identifiers
1 reference